-
RSLS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
ReShape Lifesciences (RSLS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 843.00 k | 843.00 k | 843.00 k | 843.00 k | 843.00 k | 843.00 k |
Cash burn (monthly) | 103.33 k | 318.67 k | 587.00 k | 799.17 k | 103.67 k | 497.92 k |
Cash used (since last report) | 287.86 k | 887.71 k | 1.64 mm | 2.23 mm | 288.78 k | 1.39 mm |
Cash remaining | 555.14 k | -44.71 k | -792.21 k | -1.38 mm | 554.22 k | -544.05 k |
Runway (months of cash) | 5.4 | -0.1 | -1.3 | -1.7 | 5.3 | -1.1 |
13F holders | Current |
---|---|
Total holders | 13 |
Opened positions | 0 |
Closed positions | 4 |
Increased positions | 4 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 155.14 mm |
Total shares | 440.01 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Foley & LARDNER/ Fa | 133.85 k | $930.00 k |
Matthew Joseph Nachtrab Revocable Trust 2014 | 133.85 k | $930.00 k |
Domain Parters Vii L P | 62.50 k | $0.00 |
Vanguard | 49.87 k | $73.81 mm |
BLK BlackRock | 34.06 k | $50.41 mm |
STT State Street | 13.02 k | $19.26 mm |
Interwest Partners X | 6.25 k | $10.00 k |
UBS UBS | 2.89 k | $4.28 mm |
JPM JPMorgan Chase & Co. | 1.86 k | $2.75 mm |
Tower Research Capital | 1.85 k | $2.74 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 Oct 23 | Thomas Stankovich | Common Stock, $0.001 par value per share | Sell | Dispose S | No | No | 0.27 | 131 | 35.37 | 22,949 |
11 Oct 23 | Thomas Stankovich | Common Stock, $0.001 par value per share | Sell | Dispose S | No | No | 0.93 | 39 | 36.27 | 23,080 |
1 Sep 23 | Thomas Stankovich | Common Stock, $0.001 par value per share | Sell | Dispose S | No | No | 0.89 | 118 | 105.02 | 23,119 |
24 Aug 23 | Thomas Stankovich | Common Stock, $0.001 par value per share | Sell | Dispose S | No | No | 1.42 | 39 | 55.38 | 23,237 |
4 Aug 23 | Thomas Stankovich | Common Stock, $0.001 par value per share | Sell | Dispose S | No | No | 1.43 | 108 | 154.44 | 23,276 |
6 Jul 23 | Thomas Stankovich | Common Stock, $0.001 par value per share | Sell | Dispose S | No | No | 1.47 | 106 | 155.82 | 23,384 |